Polymorphous light eruption', solar urticaria2, and hydroa vacciniforme3 have been reported after moderate sun exposure. A 10-year-old girl is now described who developed purpura on exposed areas of the skin following sun exposure on at least 6 occasions. This association does not apear to have been reported previously.
Case report A 10-year-old girl was seen in April 1985 because of painless, purpuric lesions on the exposed areas of her skin. She noted the lesions 6 hours after she went swimming and was exposed to strong sunlight in the afternoon for 6 hours. Subsequently, the purpuric lesions were documented either by myself, or a dermatologist, or a haematologist on more than 6 occasions after she had been exposed to sunlight. She also noted that the skin was not sunburned when each crop oflesions developed, but that she did feel nauseated after sun exposure. She was not on any medication during this period.
The patient had idiopathic thrombocytopenic purpura in July 1984, which resolved after one month's treatment with prednisone. She had also had migraine headaches in the past.
Physical examination revealed a pleasant, well looking and well developed girl who was not in acute distress. The only pertinent findings were the scattered petechial lesions measuring 1-2 mm on the .. ... ..... Figure 1 . Distribution ofpetechiae on back; areas covered by the swimming suit were not involved exposed areas of her skin (Figure 1 ). The rest of the physical examination was unremarkable. Laboratory investigations revealed the ESR to be 3 mm/h, hemoglobin 138 g/l, white cell count 6.2 x 109/1. The platelet count, repeated on several occasions, was normal. The prothrombin time, partial thromboplastin time and bleeding time were also normal. Anti-DNA antibodies and antinuclear antibodies were negative. Urinary coproporphyrin, uroporphyrin and free erythrocyte protoporphyrin were normal. A pinch test done for amyloidosis was negative.
Discussion
Purpura is punctate cutaneous capillary haemorrhage. Generally, the causes of purpura can be classified into vascular defects, platelet abnormalities (thrombocytopenic purpura) and coagulation disorders. The latter usually present as large ecchymoses rather than petechiae. Purpura has been reported following exposure to cold4-6; it has been postulated that cold may initiate an antigen-antibody reaction4 or that cold-insoluble proteins may lead to the thrombohaemorrhagic phenomenon5. Purpura may also be psychogenic7 or factitious8. Identifying the cause ofpurpura in a child may be difficult.
The occurrence of purpura on exposed areas of the body after exposure to sunlight on at least 6 occasions makes the association more than coincidental. The actual pathogenesis is not known. In Caucasians, superficial cutaneous blood vessels are the major sites absorbing visible light (wavelength 400-700 mm); sunlight of this wavelength is then converted into heat which may cause damage to superficial microvessels in susceptible individuals, resulting in petechiae. On the other hand, it is also possible that ultraviolet light may have a direct damaging effect on the superficial vasculature, leading to petechiae.
Although this patient had had idiopathic thrombocytopenic purpura in the past, the possibility of recurrence of this disorder as a cause of her purpura is excluded by the repeatedly normal platelet counts. Other causes of purpura such as thrombocytopenia, connective tissue disease, drug eruption, corticosteroid treatment, trauma, infection, vasculitis and coagulation disorders were excluded either by history or laboratory investigations. This case suggests that sunlight may have to be considered in the differential diagnosis of purpura in addition to the above causes which are more commonly encountered. A 61-year-old woman with bilateral anorectal ulceration was investigated and treated by various specialists for nearly one year before an anocutaneous ergotism, following regular abuse of migraine suppositories, could be diagnosed. The case demonstrates the considerable diagnostic difficulties in this unusual manifestation of medicinal ergotamine intoxication.
Case report In July 1982 the patient presented with yellowish, symmetrical, anal ulcers each about 4.0 cm in diameter ( Figure 1A) . The lesions were so strikingly painful, spontaneously and at the slightest touch, that rectoscopy had to be performed under spinal anaesthesia. They extended from the dentate line to the mucosa of an otherwise normal rectum. The biopsies yielded nothing but an unspecific chronic ulcerating inflammation. The patient gave a history of Parks' haemorrhoidectomy in October 1981 with uneventful wound healing. At the beginning of December 1981 she experienced increasingly burning pain at the sites of operation, which were quite inconspicuous on several examinations at that time. Four weeks later two extremely painful ulcers developed there, and these were treated by her family doctor for four months. In April and May 1982 she received clinical treatment in a dermatological and a medical hospital without resolution of the ulcers. Syphilis, tuberculosis, fungal infection, allergy and Crohn's disease were all excluded; the last had been suspected due to concomitant, recurrent abdominal pain. A's~F igure 1. Symmetrical ulcers (A) due to ergotamine suppositories, on admission. After discontinuation of the suppositories, the ulcers showed marked granulation at 2 weeks (B), and by 10 weeks had healed (c) Her history gave no clues, and she repeatedly denied taking any drugs apart from occasional tablets for headache.
After a sigmoid colostomy without any improvement and subsequent plastic coverage by rotation flaps in August 1982, she developed multiple small ulcers in both flaps which became confluent after a fortnight, so that her condition was considerably worsened.
Self-inflicted injury was by then suspected but there was no psychiatric evidence for it. Finally, in October 1982, the remains of a suppository were found by chance in one of the dressings. Only after the chemical analysis had revealed a common type of migraine suppository (AvamigranQ), containing 1.5 mg of ergotamine-tartrate, did the patient admit to daily abuse of at least one or two of these sUppositories. She had taken them for nearly one year, initially because of her migraine but increasingly for her intolerable perianal pain. 0141-0768/86/ 070424-03/$02.00/0 o 1986 The Royal Society of Medicine
